Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

BACKGROUND: Our study retrospectively assesses the safety and efficacy of the FOLFOX (oxaliplatin, fluorouracil, and leucovorin) versus DOF (docetaxel, oxaliplatin, and fluorouracil) regimens in untreated locally advanced gastric cancer (AGC). PATIENTS AND METHODS: A total of 108 patients underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mengyao, Hu, Guofang, Wang, Yuan, Guo, Jun, Liu, Liyan, Han, Xiao, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775733/
https://www.ncbi.nlm.nih.gov/pubmed/29398919
http://dx.doi.org/10.2147/OTT.S149624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775733/
https://www.ncbi.nlm.nih.gov/pubmed/29398919
http://dx.doi.org/10.2147/OTT.S149624

Ejemplares similares